SMARCA1 and central nervous system neoplasm: Finally, forty-six primary CNS tumors across eight distinct tumor categories exhibited neither LOF SWI/SNF function, alternative genetic/epigenetic mutations with direct SWI/SNF interaction, nor aberrant ERV expression per investigation to date (Table 5).